international guideline on etiopathogenesis clinical features and complication with recent advances in ppt form
"hypertensive disorders of pregnancy" AND guidelines
hypertensive disorders pregnancy international guidelines 2024 2025 etiopathogenesis preeclampsia
hypertensive disorders pregnancy etiopathogenesis classification clinical features complications recent advances
PLEASE DO MAKE PPT
HDP Presentation v2
Presentation · PPTX
| # | Slide |
|---|---|
| 1 | Title Slide - with 4 key global statistics |
| 2 | Table of Contents |
| 3 | ISSHP 2021 Classification - all 5 categories with criteria |
| 4 | Epidemiology & Risk Factors - modifiable vs non-modifiable |
| 5 | Etiopathogenesis — Two-Stage Model - Stage 1 (silent placentation) → Stage 2 (maternal syndrome) |
| 6 | Angiogenic Imbalance - sFlt-1, PlGF, sEng with clinical biomarker utility |
| 7 | Immunologic, Genetic & Oxidative Stress Mechanisms |
| 8 | Diagnostic Criteria - BP thresholds, proteinuria, severe features table |
| 9 | Clinical Features - 6 organ systems (CV, renal, neuro, hepatic, hematologic, placental) |
| 10 | Maternal Complications - acute + long-term |
| 11 | Fetal & Neonatal Complications |
| 12 | HELLP Syndrome - Tennessee/Mississippi classification + management |
| 13 | Management Table - all HDP categories by gestational age & severity |
| 14 | Antihypertensive Therapy - doses, contraindications |
| 15 | Prevention & Prophylaxis - aspirin, calcium, emerging strategies |
| 16 | Recent Advances 2023-2026 - biomarkers, genetics, novel therapeutics, guideline updates |
| 17 | Long-term Consequences & Postpartum Care |
| 18 | Key Takeaways - 12 summary points |
| 19 | References - 15 primary sources |